BRIEF-Sino Biopharmaceutical Posts Qtrly Underlying Profit Attributable RMB976.38 Mln
May 21 (Reuters) - Sino Biopharmaceutical Ltd:
* QTRLY REVENUE RMB6,208.03 MILLION, AN INCREASE OF ABOUT 33.4%
* QTRLY UNDERLYING PROFIT ATTRIBUTABLE RMB976.38 MILLION, UP 22.4%
* BOARD HAS DECLARED PAYMENT OF A QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE FOR THREE MONTHS ENDED 31 MARCH, 2019 Source text for Eikon: Further company coverage: